◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Chugai Pharmaceutical Co., Ltd. (4519) Financial History

Name: Chugai Pharmaceutical Co., Ltd. (4519) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-08-11

Chugai Pharmaceutical Co., Ltd. (4519) operates in the Drug Manufacturers - General industry and is headquartered in Chuo, Japan with about 5,104 employees. Its market capitalization is roughly JPY 11.70 trillion. In the fiscal year ended 2025-12-31, 4519 reported JPY 1.26T in revenue and JPY 434.0B in net income.

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Interactive charts & full statements →

4519 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	JPY 1.26T	JPY 1.17T	JPY 1.11T	JPY 1.26T	—
Gross Profit	JPY 894.3B	JPY 831.2B	JPY 698.1B	JPY 783.5B	—
Operating Income (EBIT)	JPY 598.8B	JPY 542.0B	JPY 439.2B	JPY 533.3B	—
Net Income	JPY 434.0B	JPY 387.3B	JPY 325.5B	JPY 374.4B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4519 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(JPY 299.4B)	(JPY 133.2B)	(JPY 131.6B)	(JPY 138.2B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4519 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	JPY 2.47T	JPY 2.21T	JPY 1.93T	JPY 1.87T	—
Total Liabilities	JPY 442.9B	JPY 306.9B	JPY 307.0B	JPY 445.4B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4519 viewer.

4519 Metric Deep Dives

Other Companies in Drug Manufacturers - General

4578 · Otsuka Holdings Co., Ltd. — $6.60 trillion
4568 · Daiichi Sankyo Company, Limited — $5.10 trillion
4503 · Astellas Pharma Inc. — $4.24 trillion
4528 · Ono Pharmaceutical Co., Ltd. — $1.14 trillion
4536 · Santen Pharmaceutical Co., Ltd. — $625 billion
NOVN · Novartis AG — $233 billion
1093 · CSPC Pharmaceutical Group Limited — $98 billion
GSK · GSK plc — $73 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4516 All “0-9” companies 4521 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.